Technical Analysis for VAL - Valirx Plc

Grade Last Price % Change Price Change
C 10.75 -2.27% -0.25
VAL closed down 2.27 percent on Friday, March 31, 2023, on 1.29 times normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
50 DMA Support Bullish -2.27%
Stochastic Reached Overbought Strength -2.27%
Overbought Stochastic Strength -2.27%
20 DMA Support Bullish 2.38%
50 DMA Support Bullish 2.38%
Pocket Pivot Bullish Swing Setup 2.38%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Valirx Plc Description

ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the sale of self-test drug kits. Its product pipeline includes VAL101, VAL201, VAL401 and Nav3. VAL201 is an anti-cancer therapeutic drug, which is in clinical trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth including endometriosis. VAL401 is the reformulation of a generic drug for treatment of a chronic non-oncology disease in an oral capsule. VAL101 is a therapeutic based on its Gene Inactivation by chromatin engineering (GeneICE) platform. NAV3 Cancer Screening Test enables the detection of cancer cells in tissue samples. It operates through divisional companies, including ValiPharma, ValiFinn and ValiSeek.


Sector: Healthcare
Industry: Biotechnology
Keywords: Engineering Pharmaceutical Biotechnology Medicine Life Sciences Pipe Disease Clinic Cancer Oncology Clinical Trial Biopharmaceutical Biomarker Drug Development Biomarkers Cancer Screening Chemical Pathology Companion Diagnostic Prostate Cancer Treatment Of Cancer

Is VAL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 32.0
52 Week Low 8.675
Average Volume 588,701
200-Day Moving Average 13.05
50-Day Moving Average 10.16
20-Day Moving Average 9.81
10-Day Moving Average 9.88
Average True Range 0.75
RSI 58.85
ADX 16.74
+DI 21.44
-DI 15.53
Chandelier Exit (Long, 3 ATRs) 9.49
Chandelier Exit (Short, 3 ATRs) 10.94
Upper Bollinger Bands 11.06
Lower Bollinger Band 8.55
Percent B (%b) 0.88
BandWidth 25.54
MACD Line 0.03
MACD Signal Line -0.18
MACD Histogram 0.2084
Fundamentals Value
Market Cap 6.97 Million
Num Shares 64.9 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -21.50
Price-to-Sales 0.00
Price-to-Book 5.78
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.18
Resistance 3 (R3) 12.08 11.52 11.94
Resistance 2 (R2) 11.52 11.15 11.56 11.86
Resistance 1 (R1) 11.13 10.93 11.33 11.23 11.78
Pivot Point 10.57 10.57 10.66 10.61 10.57
Support 1 (S1) 10.18 10.20 10.38 10.28 9.72
Support 2 (S2) 9.62 9.98 9.66 9.64
Support 3 (S3) 9.23 9.62 9.56
Support 4 (S4) 9.33